Not Tagged
Not Tagged
['melanoma', 'biomarker', 'optima']
#esmo22 congress: non-melanoma skin cancers. #biomarkers can help physicians select with precision in a timely manner the optimal #treatment for each #patient, thus improving the risks &amp; benefits of new and existing drugs. read about ecpc's work on nmsc: 
We are the voice of over 470 cancer patient organisations, covering the most common to the rarest cancers. 

ECPC is providing Secretariat for @ChallengeCAN